This Viewpoint discusses the Food and Drug Administration granting Emergency Use Authorization of the mRNA COVID-19 vaccine BNT162b2 for children aged 5 to 11 years and the role that will play in keeping children, schools, and communities safe.
Source: JAMA Online First